Palmitoleic acid clinical trials
How each study uses palmitoleic acid is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the palmitoleic acid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Palmitoleic acid
- 2
Studies by the year they started
4 studies that test it; most in 2013 (1)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2019 | 1 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 4
Brigham and Women's Hospital (1) · University of North Carolina, Chapel Hill (1) · Chinese Medical Association (1) · National Institute of Medical Sciences and Nutrition, Salvador Zubiran (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses palmitoleic acid is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Palmitoleic Acid Combined With Infliximab for Promoting Intestinal Mucosal Healing in Crohn's DiseaseNot yet recruitingPhase 4Chinese Medical AssociationNCT07417696Written as Palmitoleic Acid + Infliximab
- Monounsaturated Fatty Acid Supplementation for Overweight and Obese Individuals With PrediabetesActive, not recruitingNot applicableBrigham and Women's HospitalNCT05560971Written as Palmitoleic acid
- Effect of Palmitoleic Acid on C-reactive ProteinCompletedNot applicableUniversity of North Carolina, Chapel HillNCT03625427Written as Palmitoleic acid, 500 mg (Dose 1)
- Effect of FAn-7 in UC ActivityStatus unknownEarly Phase 1National Institute of Medical Sciences and Nutrition, Salvador ZubiranNCT01771224Written as Palmitoleic acid
Codes
What other systems call palmitoleic acid · ClinicalTrials.gg INT002433
- MeSH (NLM) C008757palmitoleic acidConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 209B6YPZ4IPALMITOLEIC ACIDConfirmed FDA, NLM, Wikidata
- RxNorm 2475955One source FDA
- Wikidata Q412366palmitoleic acidConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C68408Palmitoleic AcidOne source FDA
- DrugBank DB04257One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C008757 | palmitoleic acid | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 209B6YPZ4I | PALMITOLEIC ACID | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2475955 | — | One source FDA |
| Wikidata | Q412366 | palmitoleic acid | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C68408 | Palmitoleic Acid | One source FDA |
| DrugBank | DB04257 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.